|
Dec 20
|
KalVista Pharmaceuticals Announces Publication of First Oral Factor XIIa Data in Frontiers in Pharmacology
|
|
Dec 7
|
KalVista Pharmaceuticals Inc (KALV) Reports Second Fiscal Quarter Results
|
|
Dec 7
|
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update
|
|
Dec 5
|
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Apr 27
|
KalVista Pharmaceuticals to Present Data at the 13th C1-inhibitor Deficiency & Angioedema Workshop
|